RXRX

#2035
Recursion Pharmaceuticals, Inc. - Class A Common Stock
3.4 5 USD
+0.88%
版块: 医疗保健
基础: USD
利润货币: USD
日范围
3.35
3.47
年范围
2.77
7.18
日变化
+0.88%
每月变动
+3.60%
6个月变化
-22.65%
年变化
-20.69%
前一天收盘价
3.4 2
Open
3.4 3
最低价
3.3 5
High
3.4 7
交易量
1 981
展开完整图表 完整图表

Financials

概览 声明 统计
每季度 年度
  • Market Capitalization 1.83 B
  • Employee 600
  • Founded 2013
  • CEO Najat Khan
  • Website www.recursion.com
  • Headquarter Delaware, United States
  • FIGI BBG00PQ4XJ45
  • Industry 生物技术
总收入
净利润
每股基本收益（基本 EPS）
总债务
自由现金流
现金及现金等价物
市盈率
-2.84
市销率
24.5

Recursion Pharmaceuticals, Inc. - Class A Common Stock

Recursion Pharmaceuticals is a clinical-stage biotechnology company that focuses on mapping and decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering. The company is based in Salt Lake City, Utah. It was founded by Chris Gibson, Dean Li and Blake Borgeson.

新闻